LMDX - LumiraDx Non-GAAP EPS of -$0.16 misses by $0.03 revenue of $21M misses by $0.48M
2023-08-24 08:18:08 ET
More on LumiraDx
- LumiraDx gains on FDA submission for COVID Ultra Test
- LumiraDx jumps 34% on U.K. approval for COVID and RSV tests
- LumiraDx wins U.S., U.K. nod for COVID/flu assay
- LumiraDx gets $14.2M in grants from Gates Foundation to develop TB test
- Seeking Alpha’s Quant Rating on LumiraDx
- Earnings data for LumiraDx
For further details see:
LumiraDx Non-GAAP EPS of -$0.16 misses by $0.03, revenue of $21M misses by $0.48M